Chris is the founding CEO of Reveal Surgical, a medical technology company dedicated to pushing the limits of cancer detection by developing optical biopsy tools based on machine learning and Raman spectroscopy. Prior to Reveal, he worked with his co-founder Dr. Kevin Petrecca, building a translational research program at the Montreal Neurological Institute focused on working with industry partners to accelerate the discovery and pre-clinical development of a wide variety of small molecules and biologics for the treatment of brain cancers. He has published numerous peer-reviewed journal articles. Prior to his work at the MNI, Chris was involved with a start-up that specialized in the application of stimuli-responsive polymer materials to a wide range of industries.